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Clive B BeggsAbstract
Venous abnormalities contribute to the pathophysiology of several neurological conditions. This paper reviews the
literature regarding venous abnormalities in multiple sclerosis (MS), leukoaraiosis, and normal-pressure
hydrocephalus (NPH). The review is supplemented with hydrodynamic analysis to assess the effects on
cerebrospinal fluid (CSF) dynamics and cerebral blood flow (CBF) of venous hypertension in general, and chronic
cerebrospinal venous insufficiency (CCSVI) in particular.
CCSVI-like venous anomalies seem unlikely to account for reduced CBF in patients with MS, thus other mechanisms
must be at work, which increase the hydraulic resistance of the cerebral vascular bed in MS. Similarly,
hydrodynamic changes appear to be responsible for reduced CBF in leukoaraiosis. The hydrodynamic properties of
the periventricular veins make these vessels particularly vulnerable to ischemia and plaque formation.
Venous hypertension in the dural sinuses can alter intracranial compliance. Consequently, venous hypertension may
change the CSF dynamics, affecting the intracranial windkessel mechanism. MS and NPH appear to share some
similar characteristics, with both conditions exhibiting increased CSF pulsatility in the aqueduct of Sylvius.
CCSVI appears to be a real phenomenon associated with MS, which causes venous hypertension in the dural
sinuses. However, the role of CCSVI in the pathophysiology of MS remains unclear.
Keywords: Venous hypertension, CCSVI, Multiple sclerosis, Leukoaraiosis, Normal-pressure hydrocephalus,
Cerebral blood flow, Cerebrospinal fluidIntroduction
The cerebral venous system is often viewed simply as a
series of collecting vessels channeling blood back to the
heart, yet it also plays an important role in the intracra-
nial hemodynamic/cerebrospinal fluid (CSF) regulatory
system (hereafter simply referred to as the hydrodynamic
regulatory system), a role that is often overlooked and
that appears to influence both perfusion of the brain
parenchyma [1,2] and the dynamics of the CSF system
[3-5]. Although the physiological mechanisms associated
with cerebral-venous outflow are poorly understood, ab-
normalities of the venous system have been implicated
in a variety of neurological disorders, including mul-
tiple sclerosis (MS) [4,6-11], leukoaraiosis [3,12-16],
vascular dementia [5,17], and normal-pressure hydro-
cephalus (NPH) [2,3]. This raises intriguing questions
about the involvement of the venous system in theseCorrespondence: c.b.beggs@bradford.ac.uk
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reproduction in any medium, provided the orpathophysiologies. Furthermore, similarities between the
intracranial hydrodynamic phenomena associated with
these conditions suggest that common physiological me-
chanisms may be at work. This paper reviews the litera-
ture relating to the role of the venous system in MS,
leukoaraiosis, and NPH, with the aim of better unders-
tanding the contribution of venous hemodynamics to
these neurological disorders.Evidence of venous involvement
Despite having very different pathologies, MS, leukoa-
raiosis, and NPH all share some common characteristics.
In all three conditions, cerebral blood flow (CBF) is
reduced [18-21]. Both MS [6,10] and leukoaraiosis
[13,14,22,23] are characterized by changes in the white
matter (WM) in the periventricular region, and enlarged
lateral ventricles are associated with both MS [24,25]
and NPH [26,27]. Furthermore, some clinical character-
istics are also shared. Gait disturbances [28-31], reduced
cognitive ability [30,32,33], and loss of bladder controlis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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This suggests that the pathophysiology of these disparate
conditions might share a common feature. Having said
this, all three diseases display marked pathophysiological
differences. For example, MS is an autoimmune disease,
characterized by brain atrophy [36,37], and it is thought
that this is primarily responsible for ventricular enlarge-
ment [24,25]. Although the ventricles are also enlarged
in NPH, brain parenchymal atrophy is not evident [26],
and a measure of ventricular normality can sometimes
be restored by the surgical insertion of a shunt to drain
away excess CSF [27,38,39]. Although MS and leukoa-
raiosis both exhibit periventricular WM changes, leu-
koaraiosis is thought to be one presentation of cerebral
small-vessel disease [40], whereas MS is a chronic in-
flammatory demyelinating disease of the central nervous
system (CNS) [41]. Consequently, MS therapies focus on
preventing axonal demyelination and promoting remye-
lination [42,43], whereas vigorous treatment of cardio-
vascular risk factors has been advocated to prevent the
development of leukoaraiosis, and to reduce the attend-
ant risk of stroke and dementia [44].Multiple sclerosis
Since the earliest years of research into MS, there has
been suspicion that the venous system might be involved
in its etiology, with Dawson [10], Putnam [6,11] and
others [45-49] all implicating veins in the pathophysi-
ology of the disease. MS plaques are often venocentric,
and frequently form around the periventricular veins [6].
Dawson [10] reported that finger-like plaques form at
the junction of the subependymal and medullary veins
in the periventricular WM. Putnam and Adler [6], com-
menting on the appearance of these ‘Dawson’s fingers’,
observed that the medullary veins were enclosed in a
sleeve of plaque, and that, adjacent to the plaques,
the veins were grossly distorted and distended. Others
[45,50-52] have also shown that inflammatory lesions
tend to form axially around veins in the WM, with
Tallantyre et al. [53] finding 80% of MS lesions to be
perivenous in nature. Kidd et al. [50] showed that le-
sions in the grey matter (GM) are also associated with
veins, with the majority of cortical lesions arising within
the territory of the principal vein, V5, whose course be-
gins in the WM [54], and the remaining cortical lesions
forming in the region drained by its branches or those of
the superficial veins. Others have confirmed these obser-
vations, finding intracortical [55-57], leucocortical [55],
and sub-cortical [52] lesions to be perivenous. However,
the connection with the venous system has largely been
ignored, with the focus of MS research turning instead
towards the involvement of the immune system in the
disease [58,59].Recently, there has been renewed interest in studying
vascular changes associated with MS [60-62]. This has
been precipitated by the controversial finding that ab-
normalities in the extracranial venous system appear to
be associated with the disease [4,7,8,63]. This condition,
known as chronic cerebrospinal venous insufficiency
(CCSVI), is characterized by multiple intraluminal sten-
otic malformations of the principal venous-drainage
pathways, particularly in the internal jugular veins (IJVs)
and the azygos vein, and has been shown to be associ-
ated with impaired blood flow from the brain to the
heart in patients with MS [8], with the hydraulic resist-
ance of the cerebral-venous drainage system being on
average 63.5% greater in CCSVI-positive individuals [64].
CCSVI also appears to be associated with changes in the
intracranial vasculature, with a strong correlation shown
between CCSVI severity and decreased CBF in both the
WM and GM of patients with MS [65]. In addition,
Zivadinov et al. [9] reported a marked reduction in
venous vasculature visibility (VVV) on susceptibility-
weighted imaging (SWI) for cerebral veins of less than
0.3 mm diameter in patients with MS compared with
controls, a phenomenon that is strongly statistically as-
sociated with CCSVI (P < 0.0001). This finding appears
to corroborate the work of Ge et al. [66]. However,
unlike Ge et al., who attributed the reduction in VVV
to hypometabolic status in the brain parenchyma of
patients with MS, Zivadinov et al. performed a pre-
contrast and post-contrast SWI venography experiment,
which indicated the reduction in VVV to be due to mor-
phological changes in the cerebral veins of patients with
MS. Indeed, such was the clear-cut nature of these ven-
ous changes that Beggs et al. [67] were able to distin-
guish between patients with MS and healthy controls
with 100% accuracy using cerebral-venous data alone.
These findings reinforce a large body of evidence
connecting MS with alterations in the cerebral vascular
bed. Using tomography, a number of early investigators
[68-71], found reduced CBF in the GM and WM of
patients with MS. However, this work received little
attention and it was not until the advent of magnetic
resonance imaging (MRI) that interest was renewed [61].
Using dynamic susceptibility contrast-enhanced MRI, Law
et al. [18], identified a 53.4% decrease in CBF throughout
the normal-appearing white matter (NAWM) in patients
with relapsing–remitting (RR) MS compared with con-
trols. This was accompanied by a twofold increase in vas-
cular mean transit time (MTT), and a 13.6% decrease in
WM cerebral blood volume (CBV). Adhya et al. [21] stud-
ied tissue perfusion in the NAWM of patients with pri-
mary progressive MS, relapsing-remitting (RR) MS, and
healthy controls. They also found CBF and CBV to be sig-
nificantly decreased in all NAWM regions in both forms
of MS compared with controls. Similarly, Ge et al. [19]
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the NAWM to be a feature of MS. Varga et al. [20]
reported blood flow to be particularly low in the peri-
ventricular region, with CBF in the NAWM in this region
being significantly lower in patients with MS compared
with controls. Interestingly, they also found CBF to be
decreased in the sub-cortical normal-appearing grey mat-
ter in patients with RR MS, suggesting a continuum of
decreased tissue perfusion, beginning in the WM and
spreading to the GM as the disease progresses [60]. Col-
lectively, these findings indicate that hypoperfusion of the
WM is a consistent phenomenon in MS, whatever the dis-
ease subtype [61]. Several researchers have also found MS
to be associated with reduced CBF in the GM. Rashid et al.
[72] found hypoperfusion in several cortical areas of pa-
tients with RR and progressive MS. Investigating tissue per-
fusion in the thalamus, putamen, and caudate nuclei of
patients with MS, Inglese et al. [73] found a decrease in
CBF in the deep GM, the magnitude of which increased
with the severity of the disease. These findings, along with
those relating to the WM, suggest that MS is associated
with systemic changes in blood flow through the cerebral
vascular bed, something highlighted by Mancini et al. [74],
who found the mean tissue-vein transit time to be 3.2 -
seconds in patients with MS, compared with only 2.9
seconds in healthy controls.
Venous hypertension in the dural sinuses is known to
inhibit absorption of CSF through the arachnoid villi
(AV) [75,76]. Zamboni et al. [4] reported reduced CSF
net flow and increased CSF pulsatility in the aqueduct of
Sylvius (AoS) in patients with MS, and found this to be
strongly associated with CCSVI severity. Magnano et al.
[77] also found MS to be strongly associated with in-
creased aqueductal pulsatility and reduced CSF net flow.
Although Magnano et al. did not specifically consider
CCSVI, their findings are consistent with those of
Zamboni et al., and suggest that venous hypertension
may be a feature of MS. Abnormal CSF hydrodynamics
have also been implicated in the formation of cortical le-
sions in MS. Sub-pial lesions, which appear not to be
perivenous, cover extensive areas of the cortex, and ex-
tend from the surface into the brain [55]. They appear
to be mediated by infiltrates, generated by inflammatory
cells in the meninges or the CSF, which diffuse inwards
from the surface of the brain [55,78]. Kutzelnigg et al.
[79] found sub-pial demyelination to be most pro-
nounced within deep invaginations of the cortex, and
suggested that this reflected regional differences in CSF
flow, with extensive demyelination occurring in areas of
CSF stasis.
Leukoaraiosis
Leukoaraiosis is a radiological finding, characterized by
WM hyperintensities in the periventricular region onT2-weighted MRI scans [80], which is associated with
diverse clinical symptoms, including cognitive impair-
ment [81], vascular dementia [82,83], gait disturbance
[30], and enhanced risk for stroke [84]. Although leu-
koaraiosis is primarily a pathology associated with aging
[83,85], it shares several similarities with MS [62,86,87].
Both diseases affect the WM and are associated with
demyelination [13,82]. In a similar manner to MS,
leukoaraiosis is characterized by WM morphological
changes around the periventricular veins [13,14,22,23].
Although not fully understood, leukoaraiosis is thought
to be associated with chronic cerebral ischemia [88]. In
cases of hypoxic/ischemic injury, histological changes of
the WM can range from coagulative necrosis and cavita-
tion to non-specific tissue changes such as sponginess,
patchy demyelination, and astrocytic proliferation [88].
Such changes are consistent with the lesions seen in pa-
tients with leukoaraiosis [89], suggesting that ischemia is
closely associated with the condition [88]. In particular,
leukoaraiosis is characterized by non-inflammatory col-
lagenosis of the periventricular veins [13,22], resulting in
thickening of the vessel walls and narrowing, or even
occlusion, of the lumen [13]. Moody et al. [13] found a
strong association between the probability of severe leu-
koaraiosis and periventricular venous collagenosis (PVC).
Mirroring the cerebral hemodynamics of MS, several
researchers have reported leukoaraiosis to be associated
with reduced CBF [23,83,90,91]. However, unlike MS, a
strong epidemiological link exists between leukoaraiosis
and cerebrovascular disease [92-94]. Arterial hyperten-
sion and cardiac disease are also risk factors that are fre-
quently associated with leukoaraiosis [88], and these are
thought to induce arteriolosclerotic changes in the arte-
ries and arterioles of the WM, replacing the smooth
muscle cells by fibro-hyaline material, causing thickening
of the vessel walls and narrowing of the vascular lumen
[95]. Indeed, arteriolosclerosis is often present within
areas of leukoaraiosis [96,97]. Furthermore, the arterioles
supplying the deep WM, which are some of the longest
in the brain, frequently become tortuous with aging
[23,98-100], with the result that there is a trend towards
increased tortuosity in individuals with leukoaraiosis
[23]. This tortuosity usually begins abruptly as the arteri-
ole passes from the cortex into the WM [23], and greatly
increases the vessel length. Given that this will increase
the hydraulic resistance of the arterioles [99], it will tend
to inhibit the blood flow to the deep WM. It is therefore
perhaps not surprising that the periventricular veins,
being a ‘distal irrigation field’ [88], are prone to is-
chemic damage under conditions of moderate deficit
in blood flow.
Further evidence linking leukoaraiosis with altered
venous hemodynamics comes from a series of studies by
Chung and co-workers [15,16,101], who investigated
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the IJVs) in older individuals. They found JVR to be a
phenomenon that increased with age, and concluded
that it was associated with more severe age-related WM
changes (leukoaraiosis) [16]. In particular, they found
that the IJV lumen cross-sectional area increased with
age [101], which suggests dilation of the veins due to in-
creased venous pressure and reduced flow velocity.
Chung et al. [101] suggested that if the venous hyperten-
sion exceeds the ability of the dilation to compensate for
the additional pressure, then it would compromise the
competence of the jugular venous valves, with the result
that the direction of venous flow could be reversed.
They further hypothesized that this ‘chronic or long-
term episodic elevated cerebral-venous pressure might
cause cerebral venule hypertension, resulting in. . . re-
duce[d] CBF since elevated cerebral venule pressure
would lower cerebral perfusion pressure’ [15].
In a series of studies, Bateman and co-workers inves-
tigated altered venous hemodynamics in a variety of
neurological conditions [2,3,5,17,102,103]. In particular,
they investigated pulsatile blood flow in leukoaraiosis [3]
and vascular dementia [5]. In both conditions, they
found venous pulsatility to be greatly increased in the
straight sinus compared with healthy controls, implying
that in individuals with leukoaraiosis and vascular de-
mentia, the blood flow through the WM is highly pulsa-
tile. Given that blood flow through the cerebral vascular
bed is generally non-pulsatile in healthy young adults
[3,104], Bateman’s findings imply marked changes in
hemodynamic behavior in individuals with leukoaraiosis
and vascular dementia, something that will induce tran-
sient shear stresses on the endothelia. Given that vessels
experiencing highly oscillatory flows also seem to be
at high risk of developing arteriosclerosis [105], it is
perhaps not surprising that leukoaraiosis is associated
with morphological changes in the WM vasculature
[13,14,22,23]. Bateman hypothesized that the increased
pulsatility exhibited by the CBF was a direct conse-
quence of a dysfunctional windkessel mechanism [3,5],
implying profound alterations in the dynamics of the
CSF system. Indeed, Bateman calculated the CSF pulse
volume in severe cases of leukoaraiosis to be 46% greater
than that in healthy controls [3]. Furthermore, he found
that the CSF dynamics associated with leukoaraiosis de-
layed the egress of blood from the cortical veins into the
superior sagittal sinus (SSS), inducing a complex pulse
wave, which propagated backwards towards the capilla-
ries of the cortex [3].
Normal-pressure hydrocephalus
NPH occurs when there is an abnormal accumulation
of CSF in the ventricles, causing them to become en-
larged [27], but with little or no increase in intracranialpressure (ICP). Most adults with the condition experi-
ence an ICP that is not unusually high, being generally
less than 15 mmHg [106,107]. NPH is characterized by
gait disturbance, urinary incontinence, and dementia
[108]. Although its pathophysiology is poorly under-
stood, NPH has traditionally been thought to be a form
of communicating hydrocephalus, characterized by poor
absorption of CSF into the SSS due to defective AV
[109]. However, evidence supporting this opinion is
lacking [109], and several commentators have sugges-
ted alternative theories [2,102,110-112]. In particular,
there is growing evidence that reduced intracranial com-
pliance [2,102,113,114], induced by venous hypertension,
might be involved in the pathophysiology of NPH
[2,102,115,116], although this opinion is disputed by
others [26,117,118]. Bateman [102] found the arterioven-
ous delay (AVD), a general marker of intracranial com-
pliance, to be 53% lower in patients with NPH compared
with healthy controls. A similar reduction in AVD in pa-
tients with NPH was reported in a subsequent study [2].
Mase et al. [114] independently confirmed this finding,
showing a 64% reduction in intracranial compliance in
patients with NPH compared with controls. The fact
that an AVD exists at all indicates the presence of com-
pressible material within the intracranial space, which is
deformed when the systolic arterial pulse enters the cra-
nium. With respect to this, the cerebral veins are a likely
candidate [115,116]. Approximately 70% of intracranial
blood volume is located within the venous compartment,
much of it in thin-walled veins that readily collapse
under small changes in transmural pressure. Given that
the intracranial veins, particularly those of the superficial
venous system, are much more compliant than the arter-
ial vessels, it has been suggested that the change in
intracranial compliance seen in patients with NPH may
be associated with venous hypertension [2]. In patients
with NPH, cortical-vein compliance is significantly re-
duced [102]; however, following shunt surgery, compli-
ance greatly increases, suggesting that the compliance
changes associated with these veins are functional and
not structural [2,102]. NPH has been shown to be asso-
ciated with venous hypertension in the SSS [119]. It is
therefore plausible that hypertension in the SSS might
increase the pressure in the cortical veins, with the result
that the functional compliance of these vessels is re-
duced [2]. Furthermore, venous hypertension in the SSS
would tend to reduce the compliance of the AV, and
this, together with reduced cortical-vein compliance,
might account for the reduction in AVD seen in indivi-
duals with NHP.
CBF has been found to be lower in patients with NPH
than in normal controls [120-123]. This is generally
thought to be associated with the formation of ischemic
lesions, particularly in the deep WM [118,122,124],
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individuals with NPH. Momjian et al. [122] found the
distribution of regional CBF in the WM to be different
in patients with NPH compared with healthy controls,
with a more pronounced CBF reduction adjacent to the
lateral ventricles, and a logarithmic normalization occur-
ring with distance from the ventricles. These findings
built on an earlier study by Owler et al. [121], who
reported NPH to be associated with a marked reduction
in mean CBF in the deep GM. Momjian et al. [122] at-
tributed these phenomena to a combination of factors,
including cerebral small-vessel disease; tissue distortion,
and reversal of CSF and interstitial fluid flow, resulting
in reduced cerebral perfusion pressure (CPP) near the
ventricles and resultant ischemia. However, this inter-
pretation was challenged by Bateman [102], who found
blood flow in the straight sinus, which serves the peri-
ventricular region, to be unchanged in patients with
NPH compared with controls. Having said this, Bateman
also reported 27% less drainage from the SSS in patients
with NHP compared with healthy controls. Although
Bateman’s findings concerning the blood flow through
the deep venous system are difficult to explain, those re-
lating to the superficial venous system, might help to ex-
plain the formation of cortical infarcts in patients with
NPH reported by Tullberg [124].
A number of researchers have reported marked alter-
ations in CSF dynamics in NPH, with CSF pulsatility in
the AoS found to be markedly greater in patients with
NPH compared with controls [112,125-129]. This mir-
rors the findings of Magnano et al. [77], who found a
similar phenomenon in patients with MS. By contrast,
the cervical CSF pulse was either unchanged [112] or ac-
tually reduced in individuals with NPH compared with
controls [126]. Although the reasons for this apparent
paradox are difficult to explain, it suggests that biomech-
anical changes occur with NPH, which alter both intra-
cranial compliance and pulsatility of the cerebral venous
and arterial blood flows. NPH also appears to be asso-
ciated with significantly reduced CSF resorption into the
SSS through the AV [26,130], which is a finding con-
sistent with venous hypertension in the dural sinuses.
Drainage of CSF into the dural venous sinuses requires
a pressure gradient between the sub-arachnoid space
(SAS) and the SSS of about 5 to 7 mmHg [131,132]. If
the pressure in the SSS is increased, then either the ICP
must also increase to facilitate CSF absorption through
the AV [117], or alternatively the CSF must be absorbed
elsewhere in the intracranial space. Given that ICP does
not substantially increase in individuals with NPH, this
indicates that CSF is being resorbed elsewhere [124].
Bateman [102] suggested that CSF resorption is likely to
occur in the sub-ependymal brain parenchyma. Ventricu-
lar reflux of fluid has been shown to be a characteristic ofcommunicating hydrocephalus [133,134], with the pe-
riventricular tissue characterized by disruption of the
ependyma, and by edema, neuronal degeneration, and is-
chemia [124]. Although the hydrodynamics associated
with ventricular reflux are poorly understood, it may be
that reduced CSF absorption by the AV in individuals with
NPH at least partly explains the increase in aqueductal
CSF pulsatility that is associated with the condition [133].
Mass transfer and spatial proximity
Although there are clear differences in the pathologies
of MS, leukoaraiosis and NPH, there are also striking
similarities. All three are characterized by: 1) WM changes
in the periventricular region; and 2) reduced CBF. The le-
sions associated with both MS and leukoaraiosis tend to
be perivenous in nature, and the changes in CSF dynamics
associated with NPH and MS also reveal similarities. This
raises intriguing questions as to why these similarities
exist. Are there some underlying physical mechanisms
that are common to all these conditions?
The proximity of immune-cell aggregations to the vas-
culature is a hallmark of MS [135]. Whereas much at-
tention has been paid to the biological mechanisms
involved in the formation of MS plaques, the impli-
cations associated with their spatial arrangement have
largely been ignored. Why do MS plaques form next to
veins rather than capillaries, and why do they consist-
ently occur in some places and not others? In nature,
when a process is truly random, events tend to be widely
distributed, with no underlying pattern. Conversely, if
there is an underlying phenomenon, then the events will
tend to cluster in both time and space. The fact that MS
plaques consistently form around the periventricular
[136] and cortical [50] veins indicates that the latter, ra-
ther than the former process must be taking place. If this
were not so, then lesions would be randomly distributed
throughout the brain parenchyma. From this, it can be
concluded that in MS some unknown, but consistent,
phenomenon is at work, which causes plaques to form
around certain cerebral veins. Although historically con-
sidered a disease primarily affecting the WM, it is now
known that cortical demyelination is common in MS
and more extensive than previously appreciated [78,137].
Although it has been reported that many intra-cortical
and sub-cortical lesions are perivenous in nature
[50,52,55-57], it is not known why this is so. However,
the fact that MS plaques form in the vicinity of veins in
both the deep and superficial systems suggests that the
pathophysiological mechanisms at work are extensive
and not confined to a focal region.
Another universal principle found in nature is that of
mass transfer. In simple terms, in order for matter to
move from one place to another, it must be transported
by some mechanism. In biology, the transport of cells
Beggs BMC Medicine 2013, 11:142 Page 6 of 17
http://www.biomedcentral.com/1741-7015/11/142and chemicals generally occurs either by: diffusion, by
active transport (in the case of ion transport across the
cell membrane), or through transport in a bulk fluid
such as blood. If diffusion or active transport are the
mechanisms at work, then there is a tendency towards
higher concentrations of the transported substance near
its source and lower concentrations further away. If this
simple logic is applied to the formation of perivenous
MS lesions, it would suggest that the plaque formation
emanates from the blood vessels, rather than the other
way round. Indeed, the current thinking appears to sup-
port this, suggesting that in MS, plaque formation is pre-
cipitated by breaching of the blood–brain barrier (BBB)
[51,138,139]. If the diffusion principle is applied to the
observation by Momjian et al. [122] that in patients with
NPH the CBF steadily increases the further away from
the lateral ventricles, then it suggests that the unknown
factor inhibiting blood flow is emanating from the lateral
ventricles, which suggests that ventricular fluid reflux
might be involved.
The mass transport associated with bulk fluids also
appears to offer insights into the spatial arrangement of
ischemic WM changes, such as those found in leu-
koaraiosis. Considering oxygen transport in the blood
through the cerebral vascular bed, the law of mass trans-
port dictates that as oxygen is supplied to the brain par-
enchyma, so the oxygen levels in the blood will decrease.
Consequently, the oxygen tension in the cerebral arteries
will be higher than that in the cerebral veins. Under
normal circumstances, this should not cause any prob-
lems, but when CBF is greatly impaired, as in both
leukoaraiosis [23,83,90,91] and MS [18-21], then this
might create pathogenic conditions in the distal veins. If
the oxygen consumption of the endothelia and brain
parenchyma surrounding the arterioles and capillary bed
is not downregulated, then the oxygen tension in the
veins might become so low that ischemic damage could
occur in these vessels. With respect to this, the periven-
tricular WM, being at the distal end of the circuit [88],
appears to be particularly vulnerable to ischemic damage
when blood flow is reduced. If ischemic damage due to
hypoperfusion is involved in the formation of MS le-
sions, as some have suggested [60,61], then this might
explain why plaques tend to form around the veins, ra-
ther than the capillaries and arterioles.
Hypoxia
There is increasing evidence that hypoxia-like metabolic
injury may be a pathogenic component in the formation
of MS lesions [62,86]. Wakefield et al. [140] found
morphological changes in the venous endothelia, which
progressed to occlusive vascular inflammation. They
proposed that these changes were the precursor to lesion
formation, and suggested that demyelination in MS mayhave an ischemic basis. Aboul-Enein and Lassmann
[141] reported similarities between the tissue injury
found in inflammatory brain lesions and that found in
hypoxic conditions of the CNS. Ge et al. [142] identified
subtle venous wall signal changes in small MS lesions,
which they interpreted as early-stage vascular changes.
These changes may be the result of early ischemic injury,
marking the beginning of trans-endothelial migration of
vascular inflammatory cells, before any apparent BBB
breakdown. Further evidence that focal inflammatory
BBB leakage may not be the initiating event in MS
plaque formation comes from Werring et al. [143], who
measured random motion of water molecules (apparent
diffusion coefficient; ADC) in the NAWM of patients
with MS. They found that the formation of lesions was
preceded by subtle progressive alterations in tissue in-
tegrity. Similarly, Wuerfel et al. [144] found that changes
in perfusion parameters (CBF, CBV and MTT) were de-
tectable not only prior to BBB breakdown, but also prior
to increases in the ADC. They concluded that in MS, in-
flammation is accompanied by altered local perfusion,
which can be detected prior to permeability of the BBB.
Commenting on this, D’haeseleer et al. [60] concluded
that ‘focal ischaemia might play a part in the deve-
lopment of a subcategory of focal MS lesions’. Lochhead
et al. [145], using a rat model, showed that hypoxia
followed by re-oxygenation altered the conformation of
the occlusion in the tight junctions between the endo-
thelial cells, resulting in increased BBB permeability. In
doing so, they confirmed the findings of earlier studies
undertaken by the same team [146,147]. The earliest de-
tectable event in the development of WM lesions is
thought to be an increase in the permeability of the BBB
[51], followed by inflammation and demyelination.
Others have implicated tight-junction abnormalities in
increased BBB permeability and lesion formation in MS
[139,148,149].
Several researchers have found similarities between
leukoaraiosis and MS [60,61]. Leukoaraiosis is character-
ized by periventricular hyperintensities [80] and reduced
CBF in the WM [150]. Its clinical symptoms include
cognitive features that are similar to those associated
with MS [151]. Graumann et al. [152], investigating gene
expression in the NAWM of patients with secondary
progressive MS and healthy controls, showed that the
patients with MS exhibited consistent differences in the
expression of hypoxia-inducible factor (HIF)-1a com-
pared with controls. Similar upregulation of HIF-1a in
cerebral WM was found by Fernando et al. [153] to be
associated with leukoaraiosis, which they attributed to
WM hypoperfusion. Leukoaraiosis is associated with sig-
nificantly decreased CBF in the deep WM [150], and it
is thought that ischemia, resulting from poor perfusion,
is a major contributing factor [12,13,22]. The condition
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thickening of the vessel walls and narrowing of the deep
cerebral veins [13,22], which will inevitably increase the
hydraulic resistance of these pathways. Although lu-
menal narrowing of the periventricular veins has not
been reported in patients with MS, Putnam and Adler
[6] reported that the periventricular MS plaques resulted
in gross distension of the medullary veins upstream of
the lesions, suggesting that venous stenosis is occurring.
This would inevitably increase the hydraulic resistance
of these vessels and promote hypoperfusion. Given that
the perfusion pressure, which promotes blood flow, is
relatively low in the periventricular veins, the WM in
this region is particularly sensitive to fluctuations in total
CBF [154]. Any increase in the hydraulic resistance of
the periventricular veins might cause shunting of blood
away from these vessels [22,155], an action that would
also tend to promote ischemia.Venous architecture
So why should some regions of the brain be more
vulnerable than others to damage? Perhaps the architec-
ture of the cerebral-venous system provides some clues?
While the distal venous regions may be prone to hypoxic
stress, the spatial arrangement of the veins may also
contribute to their vulnerability. Evidence in support this
opinion comes from Schlesinger [155], who forced hot
carmine–gelatin solution, under high pressure, into the
vein of Galen in human cadaver brains. The extravasa-
tions that were produced, chiefly in the region of the
angle of the lateral ventricle, ‘closely resembled the distri-
bution and shape of plaques in advanced cases of MS’.
From this, Schlesinger concluded that: ‘it seems possible
that the plaques may only be found in this area of the
ventricular wall because they have a definite topograph-
ical relationship to the veins which are crowded together
in the region of the lateral ventricular angle.’ Although
the physiological implications of Schlesinger’s experi-
ment are debatable, his results are clear and unambigu-
ous from a fluid-mechanics point of view. When the
gelatin solution was forced into the deep venous system,
it divided and flowed up the two internal cerebral veins,
so that both hemispheres of the brain were affected.
Furthermore, the fluid flowed relatively easily until it
came to the junction between the medullary and sub-
ependymal veins, where the resistance was so great that
the pressure built up to such an extent that the fluid
burst through the vessel wall. The experiment therefore
indicates two things: first, that the junction between the
medullary and sub-ependymal veins has a much higher
resistance to fluid flow than the downstream veins; and
second, that the vessel walls at this junction are suscep-
tible to rupture if the pressure gets too high.The finding that the junction between the medullary
and sub-ependymal veins has a high resistance to fluid
flow is no surprise. The sub-ependymal veins are collec-
ting vessels, which receive venous blood from a large
number of the smaller medullary veins that enter the
sub-ependymal veins at approximately 90 degrees. From
a fluid-mechanics point of view, this is not a very
streamlined configuration, and will result in relatively
large pressure drop across this junction. Any stenosis at
this junction would therefore greatly increase its resis-
tance, possibly leading to distension of the upstream
medullary veins, as Putnam and Adler reported [6]. Con-
sequently, the periventricular veins share characteristics
normally associated with developmental venous anoma-
lies (DVAs). DVAs are a venous confluence in which a
single collecting vessel drains an abnormally large ven-
ous territory, resulting in a relative volume overload.
This anatomic configuration, as San Millán Ruíz et al.
[156] pointed out, is similar to that encountered in the
periventricular region. In addition, DVAs have been
shown to have thickened walls [156], similar to those as-
sociated with PVC [13,22], with stenosis of the collecting
vein reported in 13.1% of patients [156]. Stenosis of this
kind invariably increases the hydraulic resistance of the
vein, so that the upstream pressure is greatly increased,
as was shown by Dillon [157], who measured a 15 mmHg
pressure gradient across a stenosis of the collecting vein
of a DVA in one patient.
Unlike the deep venous system, the superficial system
has thin-walled cortical bridging veins that traverse the
SAS. Blood flow through these compliant vessels is con-
trolled by sphincters, which regulate discharge into the
SSS [158,159]. This means that these vessels possess
characteristics similar to those of a Starling resistor
[160-163], and these collapse, occluding the blood flow,
when the transmural pressure reaches a certain thres-
hold [164]. The cortical bridging veins are very sensitive
to small changes in transmural pressure. Indeed, because
they are required to ‘open’ and ‘close’ to regulate blood
flow from the cortex, the cortical venous pressure is only
about 2 to 5 mmHg higher than the ICP [164]. This
means that small changes in ICP or venous pressure can
have a substantial effect on the behavior of blood flow
from the cortex. Indeed, it has been estimated that a
change of as little as 1.5 mmHg in the difference bet-
ween ICP and the pressure in the bridging veins could
be responsible for the difference between severe hypere-
mia (CBF = 1000 ml/min) to serve ischemia (CBF =
300 ml/min) [164]. Given that MS may be associated
with venous hypertension in the dural sinuses of greater
than 2 mmHg [165], it can be hypothesized that this
could have a profound effect on blood flow in the cortex.
Although it is difficult to say how this might influence
hemodynamic behavior in the cortex, it is notable that
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to be exclusively located adjacent to cortical veins.
Drawing an analogy with WM lesions, they stated; ‘We
have been able to show that there is a clear relationship
between the site and characteristics of cortical lesions
and the five different types of cortical vein, just as
Dawson’s ‘fingers’ arise adjacent to veins in periventricu-
lar WM’ [50].
Cerebrospinal fluid dynamics and venous hypertension
MS, leukoaraiosis, and NPH all appear, to a greater or
lesser extent, to be associated with marked changes in
the dynamics of the intracranial CSF system. This sug-
gests that these diseases might be associated with al-
terations in the intracranial hydrodynamic regulatory
system, which controls the volume and pulsatility of the
blood in the cerebral vascular bed [3,166,167]. The inter-
actions between the CBF and CSF are illustrated in
Figure 1, which shows an idealized model of the princi-
pal intracranial fluid pathways. From this, it can be seen
that there is a bulk flow of CSF from the choroid plexus
to the SSS, via the AV, driven by the pressure gradient
between the two. There is also a complex windkessel
mechanism that ensures Monro-Kellie homeostasis, which
compensates for transient increases in CBV by pushing
CSF out of the cranium [168]. This sophisticated wind-
kessel mechanism uses the CSF to dampen the arterial
pulse and to ensure, in healthy young adults, the smoothFigure 1 Hydrodynamic model of the brain, showing the
interactions between the arterial and venous blood flows and
the cerebrospinal fluid (CSF). SSS, superior sagittal sinus; STS,
straight sinus; SAS, sub-arachnoid space; AV, arachnoid villi; CP,
choroid plexus; FM, foramen magnum; WM, windkessel mechanism;
SR, Starling resistor; VL, lateral ventricle; V3, third ventricle; V4, fourth
ventricle; AoS, aqueduct of Sylvius; IJV, internal jugular vein; VV,
vertebral veins.flow of blood through the capillary bed [5]. The energy
from the arterial pulse is transferred to the CSF, which
pulses backwards and forwards across the foramen mag-
num. The blood flow through the cerebral capillary bed is
normally smooth and free from a pulse, but by the time it
reaches the venous sinuses, it once again exhibits pulsatile
characteristics [3,169]. This suggests that energy trans-
ferred from the arterial pulse to the CSF is in turn trans-
ferred back to the venous-discharge flow.
The various pulses associated with the intracranial
hydrodynamic system are illustrated in Figure 2, which
shows the transient flow rates of the arterial, venous,
and CSF flows in and out of the cranium in a healthy in-
dividual [169]. From this, it can be seen that the system
is driven by the arterial pulse, which, as it enters the cra-
nium, greatly increases the volume of blood in the pial
arteries during systole [1]. Peak CSF flow through the
foramen magnum occurs shortly after the arterial peak,
which is in turn followed in late systole by a peak in the
venous blood flow leaving the cranium. This movement
reflects the transfer of kinetic energy from the arterial to
the venous pulse via the CSF system. By comparison, the
aqueductal CSF pulse, which is not well understood, is
much smaller than, and out of phase with, the cervical
CSF pulse. In theory, according to the Monro-Kellie
doctrine, at any point in time, the volume of CSF leaving
the cranium should be equal to the volume difference
between the arterial blood entering the cranium and the
venous blood leaving it [170]. In reality, however, the
Monro-Kellie doctrine is only approximately true [170],
and compliance within the intracranial space, together
with inertial forces associated with the CSF fluid column,
ensure that small transient imbalances occur between the
fluid volumes entering and leaving the cranium.
Close inspection of Figure 2 reveals an interesting and
poorly understood phenomenon. During diastole, when
the excess arterial blood stored by the windkessel me-
chanism is discharged back into the cerebral vascular
bed, the venous blood-flow rate leaving the cranium ac-
tually decreases. This implies that during this period, the
volume of venous blood in the cranium must be steadily
increasing, only to be ejected during systole. Although
the physiology associated with this mechanism is not
well understood, it seems likely that much of this blood
is stored during diastole in the cortical bridging veins
that transverse the SAS. Discharge from these veins is
controlled by regulatory sphincters [158,159]. Constric-
tion of these sphincters results in an increase in the
transmural pressure of the bridging veins, causing them
to engorge and ‘puff out’, before periodically discharging
into the SSS. Thus, these sphincters, in effect, create
Starling resistors, whose characteristics are wholly gover-
ned by the respective venous and CSF pressures. Under
normal circumstances, this Starling resistor interacts
Figure 2 Transient intracranial blood and cerebrospinal fluid (CSF) flow rates over the cardiac cycle in a healthy individual. The figure is
based on data published by Ambark et al. [169].
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rect flow of blood into the SSS. However, if the venous
pressure in the SSS should increase, due to partial occlu-
sion of the cerebral-drainage pathways, then this would
change the functional compliance of both the AV and
the cortical bridging veins [2,102,115,116]. Under nor-
mal circumstances, the compliant AV dampen the sys-
tolic CSF pressure wave as the wave travels along the
SAS, thus reducing the pressure that it exerts on the
cortical bridging veins. Venous hypertension in the dural
sinuses is therefore likely to reduce the time duration
between arterial initiation of the CSF pulse and impinge-
ment of that pulse on the cortical bridging veins. Fur-
thermore, it is likely to increase the intensity of the CSF
pressure wave impinging on the bridging veins, so that
the venous blood is expelled more rapidly into the SSS.
Consequently, a reduction in the time duration between
the arterial and venous peaks would be expected, which
is exactly what Bateman found in patients with NPH
[2,102]. However, the fluid mechanics associated with
this mechanism are complex and it is difficult to predict
how the system would behave under different circum-
stances. For example, if the hydraulic resistance of the
cerebral-venous drainage system is greatly increased, as
Beggs et al. [64] reported in patients with MS, then
rapid discharging of the contents of the cortical veins
might lead to a transient increase in pressure in the SSS.
How this would behave in practice is a matter of conjec-
ture. It might result in a complex reverse-pressure wave
traveling down the cortical veins, as Bateman observed
in an individual with leukoaraiosis [3], or alternatively, itcould result in venous reflux traveling up the straight
sinus, as has been suggested by Schelling [46].
Although the precise behavior of the intracranial hy-
drodynamic system under conditions of venous hyper-
tension is unknown, there is evidence that occlusion of
the venous-drainage pathways causes blood to accumu-
late within the cranium. In an experiment involving
healthy subjects, Kitano et al. [171] showed that com-
pression of the IJVs could result in an increase in intra-
cranial blood volume of 5 to 20%. Frydrychowski et al.
[1] also performed bilateral compression of the IJVs on
healthy individuals, and found that it caused a reduction
in the width of the SAS, a finding consistent with in-
creased CBV. Furthermore, these authors found that
during compression of the IJVs, the pulsatility of the pial
arteries traversing the SAS increased by 107%. This sug-
gests that occlusion of the venous-drainage pathways re-
duces compliance of the intracranial space, impairing
the windkessel mechanism, with the result that the blood
entering the cerebral microvasculature becomes more pul-
satile. Frydrychowski et al. [1] concluded that this mech-
anism potentially linked jugular-outflow insufficiency with
arterial small-vessel cerebral disease. Their work seems to
corroborate that of Bateman [5], who found vascular de-
mentia to be associated with greatly increased pulsatility
in both the basal venous and straight sinus flows.
Chronic cerebrospinal venous insufficiency
In 2009, Zamboni et al. published a paper [7] linking a
vascular syndrome, CCSVI, with MS. CCSVI is cha-
racterized by restricted venous outflow from the brain
Beggs BMC Medicine 2013, 11:142 Page 10 of 17
http://www.biomedcentral.com/1741-7015/11/142[8,64] due to occlusions, which can take several forms,
including the presence of intra-luminal septa, membranes,
and immobile valves, as well as segmentary hypoplasia of
the veins [172]. CCSVI has proven to be a highly conten-
tious issue [173,174], with a number researchers doubting
its validity as a physiological phenomenon [173,175-179].
Notwithstanding this, biomechanically, CCSVI will tend
to increase the venous pressure in the dural sinuses, which
hypothetically could alter the dynamics of the intracranial
CSF system and potentially influence CBF.
The results obtained by researchers for CCSVI have
been very mixed. For example, some researchers found
CCSVI-like venous anomalies to be strongly associated
with MS [7,63,180-186], whereas others found no signifi-
cant difference between the venous characteristics of
healthy controls and patients with MS [173,176,187-190].
Furthermore, CCSVI-like abnormalities are not exclusive
to MS, and have been found in lesser numbers in healthy
controls [74,180,191] and in those with other neurological
diseases [180]. However, a recent meta-analysis of the
published evidence showed a positive association between
CCSVI and MS, although poor reporting and marked he-
terogeneity between studies precluded any definitive con-
clusions [192].
One possible explanation for the discrepancies bet-
ween studies is the echo color Doppler sonography
(ECDS) frequently used to diagnose CCSVI. The flop-
piness of the vessels involved and the variability of the
venous vasculature can lead to erroneous results if
ECDS is not undertaken correctly [193-195]. In an
attempt to avoid these difficulties, Zamboni et al. [8] de-
veloped a non-invasive strain-gauge cervical plethys-
mography technique for characterizing cerebral-venous
drainage in patients with MS. In a blinded study invol-
ving healthy controls and patients with MS diagnosed
with CCSVI, it was found that the hydraulic resistance
of the extracranial venous system was on average 63.5%
greater in those diagnosed with CCSVI compared with
controls (P < 0.001) [64]. This corroborates the work of
Monti et al. [196], who found reduced cerebral-venous
outflow in the upright position to be strongly associated
(P < 0.0001) with MS.Chronic cerebrospinal venous insufficiency and
cerebrospinal fluid flow
Previous work [8,64,196] strongly suggests that people
diagnosed with CCSVI exhibit reduced cerebral-venous
outflow, which in some unknown way, is linked to MS.
So if CCSVI is a real phenomenon, what role might it
play in pathophysiology of MS? Is it a symptom, or part
of the etiology? Although it is not currently possible to
definitively answer these questions, it is possible, by con-
sidering the effects that occlusion of the IJVs might haveon the cerebral hydrodynamic system, to gain insights
into what might be happening.
Figure 1 describes the principal fluid pathways and in-
teractions that occur within the cranium, and is there-
fore useful as a tool with which to interpret cerebral
hydrodynamic behavior. In fluid mechanics, the flow
through any pipe or vessel is governed by the following
equation, which is analogous to Ohm’s law in electrical
engineering:
Q ¼ ΔP
R
ð1Þ
where Q is the fluid flow rate (ml/min), R is the hy-
draulic resistance (mmHg.min/ml), and ΔP represents
the pressure drop (pressure gradient; mmHg) between
the two ends of the vessel. By applying equation 1 to the
intracranial system in Figure 1, it is possible to make
predictions as to how the system would behave if the
IJVs become occluded.
One common feature of CCSVI is stenosis of one or
both of the IJVs [7,197], which will tend to increase the
hydraulic resistance of these pathways [64]. According
to equation 1, any increase in the resistance due to par-
tial occlusion of the IJVs will result in the two pheno-
mena illustrated in Figure 3. Firstly, this increase in
resistance will tend to reduce the flow rate of blood
through the IJVs, and secondly, it will increase the pres-
sure gradient through the vessel. Consequently, although
hypoperfusion will occur, hypertension will also occur
above the obstruction, as is evident by the distension
of the IJV frequently seen in patients with CCSVI
[165,197]. This increase in venous pressure will be trans-
mitted up the vessels into the SSS, which has been
shown in patients who exhibit thrombosis of the trans-
verse sinuses [198,199]. Consequently, the increase in
blood pressure in the SSS is likely to be the same order
of magnitude as that in the IJV; that is, about 2.21
mmHg, according to measurements made by Zamboni
et al. [165].
From Figure 1 it can be seen that the SSS acts as a
collecting vessel for CSF from the SAS. The CSF bulk
flow from the choroid plexus to the SSS via the AV,
which in healthy individuals is around 3.3 to 5.5 mm3/
beat (assuming 70 beats/min) [76], is very susceptible to
changes in pressure [75]. In normal healthy individuals,
the hydraulic resistance of the SAS is very low in com-
parison with the AV, which means that the outflow of
CSF from the SAS to the SSS is almost entirely deter-
mined by the AV [76]. These open up when the pressure
difference between the SAS and SSS is approximately
5 mmHg [75], allowing free absorption of CSF into the
venous blood, a process that has been shown to be
linear, with an average rate of 0.1031 ml/min/mmHg
Figure 3 Effect of stenosis on a vein. Q1, blood-flow rate through normal vein; Q2, blood-flow rate through stenotic vein; R1, hydraulic
resistance of normal vein; R2, hydraulic resistance of stenotic vein; ΔP1, pressure drop through normal vein; and ΔP2, pressure drop through
stenotic vein.
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crease of 2.21 mmHg in the SSS pressure would equate
to a reduction in CSF bulk flow of about 3.26 mm3/beat
(assuming 70 beats/min), which is close to the mean value
of 3.4 mm3/beat reported by Magnano et al. [77] for re-
duction in CSF bulk flow in patients with MS compared
with healthy controls, but somewhat lower than the mean
difference of 11.86 mm3/beat reported by Zamboni et al.
[4]. Collectively, these findings support the opinion that
venous hypertension in the dural sinuses is a feature of
CCSVI.Chronic cerebrospinal venous insufficiency and cerebral
blood flow
It is possible to gain an insight into the nature of the
hemodynamic changes associated with MS, by underta-
king simple hydrodynamic analysis of composite data
published by Varga et al. [20]. These data are presentedTable 1 Published blood-flow data in the periventricular
white matter for healthy controls and patients with
relapsing–remitting multiple sclerosis (RR MS) [20]
Source Parameter Healthy controls,
mean ± SD
Patients with
RR MS,
mean ± SD
Varga et al.,
2009 [20]
CBF, ml/100 g/min 39.73 ± 5.0 33.53 ± 6.10
CBV, ml/100 g 2.62 ± 0.60 2.40 ± 0.40
MTT, s 3.94 ± 0.70 4.33 ± 0.50
Abbreviations: CBF, Cerebral blood flow; CBV, Cerebral blood volume;
MTT, Mean transit time.in Table 1, and represent measured blood flow in the
periventricular WM.
The data in Table 1 complies with the general relation-
ship:
CBF ¼ CBV
MTT
ð2Þ
From the data it can be seen that in patients with MS,
there is a general reduction in the volume of the vas-
cular bed, which, if approximated to a series of parallel
round tubes, equates to a mean reduction in cross-
sectional area of the vessels of about 8.4% in patients
with MS. According to Poiseuille’s Law:
R∝
1
r4
ð3Þ
where R is the hydraulic resistance of the vessel (mmHg.
min/ml) and r is the radius of the vessel (mm), it can be
calculated that the 8.4% reduction in average cross-
sectional area equates to an approximately 19.3% in-
crease in hydraulic resistance. Given that the blood-flow
rate is directly proportional to the hydraulic resistance,
this means that the reduction in CBV seen in patients
with MS, is more than enough to account for the 15.6%
reduction in CBF reported by Varga et al.. According to
equation 1, hypertension in the dural sinuses would tend
to reduce the pressure gradient pushing the blood
through the cerebral veins, which in turn would tend to
inhibit blood flow. However, when we consider that the
CPP is normally in the region of 70 to 90 mmHg, it is
unlikely that venous hypertension of less than 5 mmHg,
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the large reduction in WM CBF reported in patients
with MS [18-21]. Hence, this suggests that the reduction
in CBF in patients with MS is probably due to morpho-
logical changes in the cerebral vascular bed, rather than
a straightforward reduction in perfusion pressure arising
from raised pressure in the venous sinuses. However,
this does not preclude the possibility that the reduction in
CBF may also be due to changes in behavior of the Star-
ling resistor associated with the cortical bridging veins.
Although the above analysis is somewhat simplistic, it
does illustrate that cerebral vascular volumetric changes
alone appear capable of accounting for the reduction in
CBF in the periventricular NAWM in patients with MS.
In addition, this finding mirrors those of researchers in-
vestigating: 1) reduced CBF [23,83,90,91]; and 2) WM
morphological changes around the periventricular veins
[13,14,22,23], in patients with leukoaraiosis. Although
the above analysis assumes an overall reduction in CBV
in patients with MS, this of course does not necessarily
imply that all the vessels in the WM have uniformly
narrowed, and the results reported by Putnam and Adler
[6] regarding periventricular lesions in individuals with
MS would suggest otherwise. However, in order to achieve
an 8.4% overall reduction in CBV, systemic changes must
be occurring in the WM vascular bed, rather than simply
occlusions appearing at specific focal points. The finding
by Varga et al. [20] of a 10% increase in MTT in patients
with MS closely mirrors that of Mancini et al. [74], who
reported an 8% increase in MTT. These results strongly
suggest that the hydraulic resistance of the whole intracra-
nial vascular circuit is significantly increased in patients
with MS. Indeed, it may be the case that some vessels have
disappeared completely, as reported by Zivadinov et al.
[9], which would inevitably increase the hydraulic resis-
tance of the cerebral vascular circuit.
Further evidence suggesting that occlusion of the
cerebral-venous drainage pathways might not be respon-
sible for reduced CBF in patients with MS comes from
Moyer et al. [200], who compressed the jugular veins of
patients with heart failure; Chai et al. [201], who per-
formed jugular vein ligation in a swine model; and
Bateman [202], who investigated idiopathic intracranial
hypertension associated with venous outflow stenosis.
All these researchers found occlusion of the venous
pathways to be associated with CBF rates that were
higher than normal. This counterintuitive finding could
only be physically possible if the hydraulic resistance of
the cerebral blood vessels were greatly reduced, sugges-
ting that obstruction of the venous-drainage pathways
results in vasodilatation and increased CBV. However,
studies have found CBV to be reduced by 8.4 to 13.6%
in patients with MS compared with healthy controls
[18-20], suggesting that hyperemia may not in fact be afeature of this disease. Interestingly, Chai et al. [201]
reported that cerebral oxygen consumption was signi-
ficantly increased when venous ligation was applied,
which suggests that venous hypertension might alter the
metabolism of the brain. Although the effects of venous
hypertension on cerebral metabolism are largely unex-
plored, it is known that the brain regulates blood flow
according to its metabolic needs. Consequently, it is
difficult to know the extent to which reduced CBF is ini-
tiated by venous hypertension or endothelial morpho-
logical changes, as opposed to downregulation of the
metabolic activity of the brain.
Conclusions
Although much research work has been undertaken into
the contribution of venous abnormalities to various
neurological conditions, there has generally been a lack
of any hydrodynamic analysis to interpret the data
collected. Without such analysis, it is possible to misin-
terpret results and come to potentially erroneous con-
clusions [174]. In the analytical review presented here,
we have sought to redress this issue, and have been able
to show that CCSVI-like anomalies in the extracranial
venous system are unlikely to account for the reduction
in CBF reported in patients with MS. Rather, our ana-
lysis suggests that other pathophysiological mechanisms
must be a work, which are increasing the hydraulic re-
sistance of the cerebral vascular bed in patients with
MS. Similarly, changes in the cerebral microvasculature
seem to be responsible for reduced CBF in leukoaraiosis.
CBF in the WM is markedly reduced in both MS and
leukoaraiosis, and in both conditions, lesions exhibit
signs of ischemia, although to a lesser extent in the case
of MS. Under conditions of hypoperfusion, the laws
governing mass transfer indicate that the cerebral veins
are more likely to be affected by hypoxic stress com-
pared with the arterioles and capillaries, and this might,
in part, explain why the plaques in MS tend to be
perivenular in nature. With respect to this, the hydro-
dynamic properties of the periventricular veins appear to
make these vessels particularly vulnerable to plaque
formation.
Venous hypertension in the dural sinuses seems to be
associated with marked changes in intracranial compli-
ance. There is sound theoretical reason to believe that
this will alter the dynamics of the intracranial CSF sys-
tem, which in turn may affect the finely tuned intracra-
nial windkessel mechanism. With respect to this, MS
and NPH appear to share some similar characteristics.
In particular, both conditions seem to be characterized
by increased CSF pulsatility in the AoS.
Despite conflicting studies, there is increasing evidence
that CCSVI is a real physiological phenomenon, and that
it is in some way associated with MS. The evidence from
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dynamic analysis presented here, suggests that CCSVI
causes venous hypertension in the dural sinuses. How-
ever, the role that CCSVI might play in the patho-
physiology of MS remains unclear, and more work is
urgently needed to understand the clinical relevance
of this condition.
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